To assess relapse and MRI activity in patients with multiple sclerosis (PwMS) receiving immune checkpoint inhibitor therapy (ICI).
No takes yet. Share an insight, caveat, or question.
Afzal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Neurology